James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 772 shares at $109.75 ($85K) on 2024-01-08, disclosed to the SEC on 2024-01-09.
Scheduled sale ($85k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRNA | SELL | 2024-10-08 | $43K | — | Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |